Skip to main content

Tysabri Prices, Coupons and Patient Assistance Programs

Tysabri (natalizumab) is a member of the selective immunosuppressants drug class and is commonly used for Crohn's Disease - Maintenance, and Multiple Sclerosis.

The cost for Tysabri intravenous concentrate (300 mg/15 mL) is around $8,654 for a supply of 15 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Tysabri prices

Intravenous Concentrate

Quantity Per unit Price
15 milliliters $576.93 $8,653.95

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Tysabri Coupons, Copay Cards and Rebates

Tysabri offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Tysabri Biogen Copay Program

Eligible commercially insured patients may have their medication cost lowered to as little as $0; there is an annual savings cap on the amount of assistance that patients can receive over a one-year period; for additional information contact the 800-456-2255.

Applies to:
Tysabri
Number of uses:
per prescription per year

Form more information phone: 800-456-2255 or Visit website

Tysabri Infusion Copay Assistance Program

Eligible commercially insured patients may save $250 per infusion; for additional information contact the program at 800-456-2255.

Applies to:
Tysabri
Number of uses:
per infusion

Form more information phone: 800-456-2255 or Visit website

Patient Assistance & Copay Programs for Tysabri

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Tysabri (natalizumab) Vial; Single-Use

More information please phone: 866-316-7263 Visit Website

Provider: Biogen Support Services

Eligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Relapsing form of MS
  4. The patient must also be residing in the US.
  5. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Tysabri (natalizumab) Vial; Single-Use

More information please phone: 800-456-2255 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.